These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

541 related items for PubMed ID: 22763171

  • 1. Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus.
    Moon HJ, Lee JS, Talactac MR, Chowdhury MY, Kim JH, Park ME, Choi YK, Sung MH, Kim CJ.
    Vet Microbiol; 2012 Dec 07; 160(3-4):277-89. PubMed ID: 22763171
    [Abstract] [Full Text] [Related]

  • 2. Mucosal vaccination of conserved sM2, HA2 and cholera toxin subunit A1 (CTA1) fusion protein with poly gamma-glutamate/chitosan nanoparticles (PC NPs) induces protection against divergent influenza subtypes.
    Chowdhury MYE, Kim TH, Uddin MB, Kim JH, Hewawaduge CY, Ferdowshi Z, Sung MH, Kim CJ, Lee JS.
    Vet Microbiol; 2017 Mar 07; 201():240-251. PubMed ID: 28284616
    [Abstract] [Full Text] [Related]

  • 3. Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice.
    Okamoto S, Matsuura M, Akagi T, Akashi M, Tanimoto T, Ishikawa T, Takahashi M, Yamanishi K, Mori Y.
    Vaccine; 2009 Sep 25; 27(42):5896-905. PubMed ID: 19647814
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
    Isaka M, Zhao Y, Nobusawa E, Nakajima S, Nakajima K, Yasuda Y, Matsui H, Hasegawa T, Maeyama J, Morokuma K, Ohkuma K, Tochikubo K.
    Microbiol Immunol; 2008 Feb 25; 52(2):55-63. PubMed ID: 18380802
    [Abstract] [Full Text] [Related]

  • 12. Recombinant H5 hemagglutinin adjuvanted with nanoemulsion protects ferrets against pathogenic avian influenza virus challenge.
    Wang SH, Smith D, Cao Z, Chen J, Acosta H, Chichester JA, Yusibov V, Streatfield SJ, Fattom A, Baker JR.
    Vaccine; 2019 Mar 14; 37(12):1591-1600. PubMed ID: 30795941
    [Abstract] [Full Text] [Related]

  • 13. Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge.
    Major D, Chichester JA, Pathirana RD, Guilfoyle K, Shoji Y, Guzman CA, Yusibov V, Cox RJ.
    Hum Vaccin Immunother; 2015 Mar 14; 11(5):1235-43. PubMed ID: 25714901
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection following intranasal or intramuscular vaccination of BALB/c mice.
    Mooney AJ, Li Z, Gabbard JD, He B, Tompkins SM.
    J Virol; 2013 Jan 14; 87(1):363-71. PubMed ID: 23077318
    [Abstract] [Full Text] [Related]

  • 16. Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant.
    Sui Z, Chen Q, Fang F, Zheng M, Chen Z.
    Vaccine; 2010 Nov 10; 28(48):7690-8. PubMed ID: 20870054
    [Abstract] [Full Text] [Related]

  • 17. Intranasal immunization with live recombinant Lactococcus lactis combined with heat-labile toxin B subunit protects chickens from highly pathogenic avian influenza H5N1 virus.
    Lei H, Peng X, Shu H, Zhao D.
    J Med Virol; 2015 Jan 10; 87(1):39-44. PubMed ID: 24861477
    [Abstract] [Full Text] [Related]

  • 18. Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections.
    Liu G, Song L, Reiserova L, Trivedi U, Li H, Liu X, Noah D, Hou F, Weaver B, Tussey L.
    Vaccine; 2012 Nov 06; 30(48):6833-8. PubMed ID: 23000130
    [Abstract] [Full Text] [Related]

  • 19. A nanoemulsion-adjuvanted intranasal H5N1 influenza vaccine protects ferrets against homologous and heterologous H5N1 lethal challenge.
    Smith D, Streatfield SJ, Acosta H, Ganesan S, Fattom A.
    Vaccine; 2019 Sep 30; 37(42):6162-6170. PubMed ID: 31495593
    [Abstract] [Full Text] [Related]

  • 20. Modified pulmonary surfactant is a potent adjuvant that stimulates the mucosal IgA production in response to the influenza virus antigen.
    Mizuno D, Ide-Kurihara M, Ichinomiya T, Kubo I, Kido H.
    J Immunol; 2006 Jan 15; 176(2):1122-30. PubMed ID: 16394001
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.